Anzeige - Blood biomarkers in the NAKO Gesundheitsstudie (German National Cohort) at baseline: analysis and reliability of blood biomarkers from participants enrolled at the Berlin-North study center

Nutzungsanzeige

SchlüsselNAKO-521

ProjektleitungIlais Moreno Velásquez

Genehmigt am22.12.2020

Öffentlich seit22.12.2020

ZusammenfassungThe aim of this proposal is to characterize the completeness and plausibility of baseline biomarkers from NAKO participants enrolled at the Berlin-North study center (Max-Delbrück Center for Molecular Epidemiology, MDC). In addition, we aim to analyze the intra and inter-individual variability of biomarkers over one-year in a subset of study participants.

Schlüsselwörter-

EinrichtungenMax-Delbrück-Centrum für Molekulare Medizin, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Max-Delbrück-Centrum für Molekulare Medizin (MDC)

Zurück